Clinical Study
A Randomised Controlled Trial of Efficacy of Cognitive Rehabilitation in Multiple Sclerosis: A Cognitive, Behavioural, and MRI Study
Table 2
BICAMS outcomes in treatment versus control groups.
| | Treatment () | Control () | Mean difference | 95% CI | p | Mean (SD) | Mean (SD) |
| BICAMS improvement at follow-up (time 2 versus time 1) | SDMT gain | 3.94 (5.08) | −0.63 (3.30) | 4.56 | 1.47 to 7.66 | 0.005 | CVLT gain | 6.67 (7.56) | 4.06 (10.10) | 2.71 | −3.45 to 8.87 | 0.377 | BVMT gain | 4.65 (5.18) | 1.94 (4.17) | 2.70 | −0.52 to 5.93 | 0.098 |
| | Treatment () | Control () | Mean difference | 95% CI | p | Mean (SD) | Mean (SD) |
| BICAMS improvement at follow-up (time 3 versus time 1) | SDMT gain | 3.35 (4.17) | 4.57 (7.21) | −1.28 | −5.45 to 3.01 | 0.582 | CVLT gain | 6.94 (7.01) | 7.50 (8.83) | −0.56 | −6.38 to 5.26 | 0.849 | BVMT gain | 7.29 (5.07) | 4.14 (5.32) | 3.15 | −0.68 to 6.98 | 0.105 |
|
|
SDMT: Symbol Digits Modalities Test; CVLT: California Verbal Learning Test; BVMT: Brief Visuospatial Memory Test.
|